VYGR

Healthcare

Voyager Therapeutics, Inc.

$4.42-0.46 (-9.34%)

Prev Close

$4.87

Open

$4.85

High

$4.91

Low

$4.35

Volume

784.5K

Market Cap

$228.5M

P/E

—

Div Yield

—

Over the past 12 months, insider activity at Voyager Therapeutics, Inc. (VYGR) has been exclusively selling, with 0 insider purchases totaling $0.00 and 13 insider sales totaling $318.1K. The most recent insider transaction was by Carter Todd Alfred (officer: Chief Scientific Officer), who sold $15.7K worth of shares on Feb 26, 2026. Voyager Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $228.5M.

Buys (12M)

$0.00

Sells (12M)

$318.1K

Net Activity

Net Seller

$318.1K

Active Insiders

last 12 mo

VYGR Price Chart

VYGR Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Feb 26, 2026↗	Carter Todd Alfred	officer: Chief Scientific Officer	Sell	4,174	$3.76	$15.7K	145,718
Feb 26, 2026↗	Jorgensen Nathan D.	officer: Chief Financial Officer	Sell	4,668	$3.77	$17.6K	151,416
Feb 26, 2026↗	Sandrock Alfred	director, officer: President and CEO	Sell	14,197	$3.79	$53.8K	484,060
Feb 26, 2026↗	Swartz Robin	officer: COO & CBO	Sell	6,458	$3.77	$24.3K	199,738
Feb 20, 2026↗	Carter Todd Alfred	officer: Chief Scientific Officer	Sell	3,301	$3.44	$11.4K	149,892
Feb 20, 2026↗	Sandrock Alfred	director, officer: President and CEO	Sell	11,732	$3.41	$40.0K	498,257
Feb 20, 2026↗	Swartz Robin	officer: COO & CBO	Sell	3,882	$3.44	$13.4K	206,196
Feb 18, 2026↗	Carter Todd Alfred	Chief Scientific Officer	Sell	3,301	$3.44	$11.4K	0
Feb 18, 2026↗	Sandrock Alfred	President and CEO	Sell	11,732	$3.41	$40.0K	0
Feb 18, 2026↗	Swartz Robin	COO & CBO	Sell	3,882	$3.44	$13.4K	0
Feb 11, 2026↗	Carter Todd Alfred	officer: Chief Scientific Officer	Sell	3,525	$3.85	$13.6K	153,193
Feb 11, 2026↗	Sandrock Alfred	director, officer: President and CEO	Sell	12,192	$3.78	$46.1K	509,989
Feb 11, 2026↗	Swartz Robin	officer: COO & CBO	Sell	4,569	$3.85	$17.6K	210,078

VYGR Insider Buying Activity

The following table shows recent insider purchases of Voyager Therapeutics, Inc. (VYGR) stock reported via SEC Form 4 filings.

No insider buying activity found for VYGR in the last 12 months.

VYGR Insider Selling Activity

The following table shows recent insider sales of Voyager Therapeutics, Inc. (VYGR) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Feb 26, 2026↗	Carter Todd Alfred	officer: Chief Scientific Officer	Sell	4,174	$3.76	$15.7K	145,718
Feb 26, 2026↗	Jorgensen Nathan D.	officer: Chief Financial Officer	Sell	4,668	$3.77	$17.6K	151,416
Feb 26, 2026↗	Sandrock Alfred	director, officer: President and CEO	Sell	14,197	$3.79	$53.8K	484,060
Feb 26, 2026↗	Swartz Robin	officer: COO & CBO	Sell	6,458	$3.77	$24.3K	199,738
Feb 20, 2026↗	Carter Todd Alfred	officer: Chief Scientific Officer	Sell	3,301	$3.44	$11.4K	149,892
Feb 20, 2026↗	Sandrock Alfred	director, officer: President and CEO	Sell	11,732	$3.41	$40.0K	498,257
Feb 20, 2026↗	Swartz Robin	officer: COO & CBO	Sell	3,882	$3.44	$13.4K	206,196
Feb 18, 2026↗	Carter Todd Alfred	Chief Scientific Officer	Sell	3,301	$3.44	$11.4K	0
Feb 18, 2026↗	Sandrock Alfred	President and CEO	Sell	11,732	$3.41	$40.0K	0
Feb 18, 2026↗	Swartz Robin	COO & CBO	Sell	3,882	$3.44	$13.4K	0
Feb 11, 2026↗	Carter Todd Alfred	officer: Chief Scientific Officer	Sell	3,525	$3.85	$13.6K	153,193
Feb 11, 2026↗	Sandrock Alfred	director, officer: President and CEO	Sell	12,192	$3.78	$46.1K	509,989
Feb 11, 2026↗	Swartz Robin	officer: COO & CBO	Sell	4,569	$3.85	$17.6K	210,078